Hangzhou Tigermed Consulting Co (FRA:5HZ1) Cash Flow for Dividends: €-40.0 Mil (TTM As of Mar. 2026)


FRA:5HZ1 Hangzhou Tigermed Consulting Co Ltd FRA:5HZ1
86 GF Score
Price €3.78
GF Value €5.01
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Hangzhou Tigermed Consulting Co Cash Flow for Dividends?

Hangzhou Tigermed Consulting Co FRA:5HZ1 -2.58% 86 Cash Flow for Dividends is €-40.0 Mil as of Mar. 2026. GuruFocus rates FRA:5HZ1 with a GF Score™ of 86/100 and a GF Value™ of €5.01 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Hangzhou Tigermed Consulting Co's cash flow for dividends for the three months ended in Mar. 2026 was €-1.9 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was €-40.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Hangzhou Tigermed Consulting Co's quarterly payment of dividends declined from Sep. 2025 (€-8.3 Mil) to Dec. 2025 (€-0.3 Mil) but then increased from Dec. 2025 (€-0.3 Mil) to Mar. 2026 (€-1.9 Mil).

Hangzhou Tigermed Consulting Co's annual payment of dividends increased from Dec. 2023 (€-75.8 Mil) to Dec. 2024 (€-84.2 Mil) but then declined from Dec. 2024 (€-84.2 Mil) to Dec. 2025 (€-41.7 Mil).

Hangzhou Tigermed Consulting Co Cash Flow for Dividends Related Terms

Hangzhou Tigermed Consulting Co Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Hangzhou Tigermed Consulting Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou Tigermed Consulting Co Cash Flow for Dividends Chart

Hangzhou Tigermed Consulting Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -39.49 -66.62 -75.76 -84.23 -41.67

Hangzhou Tigermed Consulting Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.45 -29.52 -8.33 -0.31 -1.88
FRA:5HZ1
86GF Score
Hangzhou Tigermed Consulting Co Ltd FRA:5HZ1
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hangzhou Tigermed Consulting Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-40.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of €-40.0 Mil mean?
Hangzhou Tigermed Consulting Co (FRA:5HZ1) has a Cash Flow for Dividends of €-40.0 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Hangzhou Tigermed Consulting Co and its competitors.
Is Hangzhou Tigermed Consulting Co's Cash Flow for Dividends too high?
Hangzhou Tigermed Consulting Co's current Cash Flow for Dividends is €-40.0 Mil. Overall, Hangzhou Tigermed Consulting Co has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hangzhou Tigermed Consulting Co's Cash Flow for Dividends compare to TMO and DHR?
Hangzhou Tigermed Consulting Co's Cash Flow for Dividends of €-40.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Diagnostics & Research company?
A good Cash Flow for Dividends depends on the Medical Diagnostics & Research industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Hangzhou Tigermed Consulting Co and its competitors. Hangzhou Tigermed Consulting Co's current Cash Flow for Dividends is €-40.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou Tigermed Consulting Co stock overvalued right now?
Based on GuruFocus' analysis, Hangzhou Tigermed Consulting Co (FRA:5HZ1) is currently considered Modestly Undervalued. The stock's GF Value™ is €5.01, compared to a current price of €3.78 — trading 24.6% below its estimated fair value. The current Cash Flow for Dividends is €-40.0 Mil. Hangzhou Tigermed Consulting Co's overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Hangzhou Tigermed Consulting Co (FRA:5HZ1), the current Cash Flow for Dividends is €-40.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hangzhou Tigermed Consulting Co (FRA:5HZ1) Overvalued in 2026?

Based on GuruFocus' analysis, Hangzhou Tigermed Consulting Co stock appears to be undervalued. The current stock price of €3.78 is trading 24.6% below its estimated GF Value™ of €5.01. GuruFocus considers Hangzhou Tigermed Consulting Co to be Modestly Undervalued.

Key valuation signals for FRA:5HZ1:

  • Cash Flow for Dividends: €-40.0 Mil
  • GF Value™: €5.01 vs. price of €3.78 (24.6% below fair value)
  • GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the FRA:5HZ1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hangzhou Tigermed Consulting Co Business Description

Other Exchanges 03347:Hong Kong300347:China
Address No. 508 Lujiatan Street, Room 601-610, 6th Floor, Puyan Sub-District, Binjiang District, Zhejiang Province, Hangzhou, CHN
Hangzhou Tigermed Consulting Co Ltd is a China-based provider of comprehensive biopharmaceutical R&D services, with an expanding world-wide presence. The Group is principally engaged in CRO services.
86GF Score

Get the complete analysis for FRA:5HZ1

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.78
Price
€5.01
GF Value